Drug Trial Radar · NCT06237426
An Evaluation of the Long-term Efficacy and Safety of Methylone for the Treatment of PTSD
Last checked: Nov 19, 2026Latest source record: Nov 16, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
44
Actual
Start
Mar 6, 2024
Primary completion
Oct 6, 2025
Study completion Oct 6, 2025
Sponsor
- Lead sponsor
- Transcend TherapeuticsIndustry
- Sponsor type
- Industry
- First posted
- Feb 1, 2024
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 71 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is an extension study of participants who previously completed a Transcend-sponsored clinical trial evaluating TSND-201 as a treatment for PTSD. Participants will be followed for up to 52 weeks. During the 52 week period, PTSD symptoms and safety will be assessed monthly. Participants' PTSD symptoms will be assessed at each observational visit and if criteria for Relapse has been met, participants may be eligible to receive a course of TSND-201 treatment.
Conditions
- Post Traumatic Stress Disorder
Interventions
MethyloneDrug
A course of treatment includes 4 weekly doses of TSND-201.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change From IMPACT-1 Baseline in Clinician Administered PTSD Scale for DSM-5 (CAPS-5) Total Severity ScoreTime frame: Week 10 and Week 16
Locations
9 sites in 3 countries. Site status is shown where the registry gives one.
Mountain View Clinical Research
Denver, Colorado
Sunstone Medical
Rockville, Maryland
Cedar Clinical Research, Inc
Draper, Utah
La Nua Mental Health Centre
Galway, Ireland
Clerkenwell Health
London, United Kingdom
Kings College
London, United Kingdom
Cambridgeshire and Peterborough NHS Foundation Trust
Cambridge, England, United Kingdom
Mirabilis Health
Belfast, Northern Ireland, United Kingdom
NHS Greater Glasgow and Clyde
Glasgow, Scotland, United Kingdom
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.